We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$107M
1-Year Est. Return
82.62%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$13.9M
(-12%)
Cap. Flow
+$1.12M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
39.11%
Holding
102
New
5
Increased
6
Reduced
39
Closed
4
Top Buys
| 1 |
Usio Inc
USIO
|
+$1.23M |
| 2 |
EMKR
Emcore Corp
EMKR
|
+$975K |
| 3 |
RGF
The Real Good Food Company, Inc. Class A Common Stock
RGF
|
+$604K |
| 4 |
Creative Realities
CREX
|
+$252K |
| 5 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
+$189K |
Top Sells
| 1 |
PFIE
Profire Energy, Inc
PFIE
|
+$901K |
| 2 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$703K |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$84.8K |
| 4 |
Option Care Health
OPCH
|
+$67.4K |
| 5 |
ePlus
PLUS
|
+$61.7K |
Sector Composition
| 1 | Healthcare | 52.28% |
| 2 | Technology | 24.79% |
| 3 | Industrials | 9.97% |
| 4 | Communication Services | 6.27% |
| 5 | Consumer Staples | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
1
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $7.16M | 7.1% |
1,391,093
-149,900
| -10% | -$703K |
|
2
Eli Lilly
LLY
$1.04T
| $7M | 6.94% |
13,032
-9
| -0.1% | -$4.64K |
|
3
Microsoft
MSFT
$2.98T
| $4.84M | 4.8% |
15,326
| – | – |
|
4
Idexx Laboratories
IDXX
$45.4B
| $4.72M | 4.68% |
10,805
| – | – |
|
5
Perion Network
PERI
$380M
| $2.94M | 2.91% |
95,935
-950
| -1% | -$31.9K |
|
6
Natera
NTRA
$38.6B
| $2.74M | 2.72% |
61,925
-275
| -0.4% | -$14K |
|
7
Veracyte
VCYT
$4.73B
| $2.67M | 2.65% |
119,680
-1,650
| -1% | -$42.4K |
|
|
PFIE
8
DELISTED
Profire Energy, Inc
PFIE
| $2.53M | 2.51% |
909,080
-444,176
| -33% | -$901K |
|
9
Abbott
ABT
$172B
| $2.46M | 2.44% |
25,380
| – | – |
|
10
Advanced Micro Devices
AMD
$817B
| $2.39M | 2.37% |
23,234
| – | – |
|
11
NeoGenomics
NEO
$1.93B
| $2.39M | 2.37% |
193,950
-2,550
| -1% | -$37.9K |
|
12
Alphatec Holdings
ATEC
$1.43B
| $2.23M | 2.22% |
172,317
-1,800
| -1% | -$28.2K |
|
13
QuickLogic
QUIK
$231M
| $1.95M | 1.93% |
226,463
| – | – |
|
14
LeMaitre Vascular
LMAT
$2.35B
| $1.93M | 1.91% |
35,436
| – | – |
|
15
Ooma
OOMA
$572M
| $1.89M | 1.88% |
145,450
-200
| -0.1% | -$2.83K |
|
16
Digi International
DGII
$2.41B
| $1.78M | 1.77% |
66,033
-825
| -1% | -$28.4K |
|
|
17
Usio Inc
USIO
$61.5M
| $1.76M | 1.74% |
1,005,193
+722,305
| +255% | +$1.23M |
|
|
CTLP
18
DELISTED
Cantaloupe
CTLP
| $1.63M | 1.61% |
260,350
| – | – |
|
19
AbbVie
ABBV
$449B
| $1.62M | 1.6% |
10,858
-150
| -1% | -$22K |
|
20
Pfizer
PFE
$143B
| $1.6M | 1.59% |
48,241
-100
| -0.2% | -$3.54K |
|
21
TELA Bio
TELA
$33.6M
| $1.52M | 1.51% |
190,500
| – | – |
|
22
Axogen
AXGN
$2.12B
| $1.51M | 1.49% |
301,340
+2,450
| +0.8% | +$17K |
|
|
STRM
23
DELISTED
Streamline Health Solutions
STRM
| $1.45M | 1.43% |
99,694
-3,189
| -3% | -$55.4K |
|
24
Inuvo
INUV
$18.3M
| $1.35M | 1.34% |
629,421
-3,650
| -0.6% | -$8.41K |
|
|
FPAY
25
DELISTED
FlexShopper
FPAY
| $1.32M | 1.31% |
1,265,040
-17,503
| -1% | -$23.1K |
|
Similar funds
EWL
ECM
HCA
LLI
CWM
SNPAM
ACL
FMI
Perkins Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Perkins Capital Management held 102 positions worth $101M, down 12% from $115M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management's Q3 2023 filing shows 5 new, 6 increased, 39 reduced and 4 closed positions. Its largest new stake was The Real Good Food Company, Inc. Class A Common Stock: 12,333 shares worth $496K. The largest sale was Profire Energy, Inc, an estimated $901K.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 55% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q3 2023 buy was The Real Good Food Company, Inc. Class A Common Stock: 12,333 shares worth $496K.
- Perkins Capital Management added most to Usio Inc in Q3 2023, an estimated $1.23M increase.
- Perkins Capital Management's biggest Q3 2023 reduction was Profire Energy, Inc, cutting an estimated $901K.
- Perkins Capital Management fully exited Paratek Pharmaceuticals, Inc. in Q3 2023, selling an estimated $30K.
- Perkins Capital Management's ten largest holdings make up 39% of its $101M portfolio in Q3 2023.
- Perkins Capital Management opened 5 new positions and closed 4 in Q3 2023.
- Perkins Capital Management's portfolio value fell 12% quarter-over-quarter to $101M.
Based on Perkins Capital Management's 13F filing for Q3 2023, filed 2 Nov 2023.